Grants and Contributions:
Agreement Number:
-
Agreement Value:
$443,216.00
Agreement Date:
Nov 1, 2017 - Oct 31, 2020
Description:
Allele-specific lowering of mutant polyQ proteins as treatment for Huntington disease, spinocerebellar ataxia type 3 and spinocerebellar ataxia type 7
Organization:
Canadian Institutes of Health Research
Location:
Vancouver, British Columbia, CA V6T 1Z1
Reference Number:
236-2017-2018-Q4-00048
Agreement Type:
Grant
Report Type:
Grants and Contributions
Additional Information:
Grant or Award spanning more than one fiscal year.
(2017-18 to 2020-21)
Recipient's Legal Name:
Hayden, Michael R
Research Organization:
University of British Columbia